USA v. GLENMARK PHARMACEUTICALS, INC., USA

  1. August 17, 2021

    DOJ Defends Glenmark, Teva Executive Interviews Abroad

    The U.S. Department of Justice has assailed assertions by Teva and Glenmark that it inappropriately used its Israeli and Indian sister agencies to force foreign executives to sit for interviews without going through counsel, arguing that the interview requests are legal and it didn't know executives were represented by American counsel.

  2. August 13, 2021

    DOJ Denies 'Rewriting' Price-Fix Indictment of Glenmark, Teva

    The U.S. Department of Justice has derided claims by Glenmark and Teva that the antitrust enforcer is trying to assert a much broader price-fixing conspiracy involving more drugs than were included in a federal grand jury indictment. 

  3. August 09, 2021

    Glenmark, Teva Say DOJ 'Rewriting' Price-Fixing Indictment

    The U.S. Department of Justice's pre-trial feud with Glenmark and Teva continued to escalate Friday in Pennsylvania federal court with the generic drugmakers accusing the DOJ of trying to add assertions of a much broader price-fixing conspiracy involving more drugs than were included in a federal grand jury indictment.

  4. August 05, 2021

    Teva Piles Onto Strong-Arm Tactic Accusations Against DOJ

    Teva Pharmaceuticals wants to hop on to Glenmark Pharmaceuticals Inc.'s emergency relief order in the two companies' criminal price-fixing case, saying the U.S. Department of Justice has also sought inappropriate post-indictment evidence from its international employees.

  5. August 03, 2021

    Glenmark Accuses DOJ Of 'Strong-Arm Tactics'

    Attorneys for Glenmark Pharmaceuticals Inc. have accused the Department of Justice of using "strong-arm tactics" to obtain post-indictment interviews with senior executives in India, doubling down on allegations of prosecutorial misconduct in the criminal price-fixing case.

  6. August 02, 2021

    DOJ Says It Told Glenmark About Compulsory Exec Interviews

    The Department of Justice says Glenmark Pharmaceuticals Inc. attorneys were aware of interviews it demanded with senior executives in India after a Pennsylvania federal judge ordered prosecutors to cut out all non-attorney contact.

  7. July 28, 2021

    DOJ Barred From Interviewing Glenmark Execs Without Attys

    A Pennsylvania federal judge instructed the U.S. Department of Justice Wednesday to stop demanding interviews with senior Glenmark executives in India without any notice to counsel, hours after attorneys for the drugmaker in the DOJ's price-fixing case against it accused the agency of prosecutorial misconduct.

  8. July 26, 2021

    Price-Fix 'Common Thread' Links Glenmark To Teva, DOJ Says

    Glenmark cannot sever the criminal price-fixing case against it from the allegations brought against fellow generic drugmaker Teva, the U.S. Department of Justice told a Pennsylvania federal judge Friday, arguing that Glenmark's bid for separate proceedings ignores significant overlap in the charges against the companies.

  9. July 02, 2021

    Glenmark Wants Criminal Price-Fix Trial Cut Off From Teva's

    Glenmark has urged a Pennsylvania federal judge in a criminal price-fixing case to wall the drugmaker off from multiple related counts against Teva, saying just one cholesterol drug ties Glenmark to the larger conspiracy allegations against the generic-drug industry.

  10. June 22, 2021

    Morgan Lewis Bows Out Of Price-Fix Case After Conflict Claim

    Amid a battle over a potential conflict of interest for the firm, Morgan Lewis & Bockius LLP has bowed out of representing Glenmark Pharmaceuticals Inc. in a criminal case over alleged price-fixing involving fellow firm client Teva Pharmaceuticals, according to a filing late Monday in Pennsylvania federal court.